Tempus AI: Taking Advantage Of Investor Myopia
Tempus AI, a leader in precision medicine, is leveraging artificial intelligence to enhance its unique data estate. The company's recent share price decline has created a favorable entry point for investors. With a growing contract backlog exceeding $1 billion and a significant increase in data licensing revenues, Tempus AI presents an attractive opportunity for risk-tolerant investors.
- ▪Tempus AI has a rapidly growing contract backlog exceeding $1 billion.
- ▪The company's share price has recently declined, compressing its valuation.
- ▪Data licensing revenues rose nearly 70% last quarter.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4907983-tempus-ai-taking-advantage-of-investor-myopia"},"author":{"@type":"Person","name":"Bert…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
